l 692429 has been researched along with ibutamoren mesylate in 11 studies
| Studies (l 692429) | Trials (l 692429) | Recent Studies (post-2010) (l 692429) | Studies (ibutamoren mesylate) | Trials (ibutamoren mesylate) | Recent Studies (post-2010) (ibutamoren mesylate) |
|---|---|---|---|---|---|
| 40 | 5 | 1 | 102 | 19 | 14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barakat, KJ; Butler, B; Chan, WW; Chen, MH; Cheng, K; Hickey, G; Johnston, DB; Nargund, RP; Patchett, AA; Tata, JR | 1 |
| Chaung, LY; Dean, DC; Nargund, RP; Patchett, AA; Pong, SS; Smith, RG | 1 |
| Patchett, AA; Smith, RG; Wyvratt, MJ | 1 |
| Svensson, J | 1 |
| Casabiell, X; Casanueva, FF; Dieguez, C; Gualillo, O; Micic, D; Pombo, M | 1 |
| Bach, MA; Fuh, VL | 1 |
| Bailey, AR; Feighner, S; Griffin, P; Howard, A; Leonard, R; Mckee, KK; Palyha, O; Pong, SS; Smith, RG; Tan, C | 1 |
| Shimatsu, A | 1 |
| Smith, RG | 1 |
| Bach, A; Brandt, E; Heding, A; Holst, B; Schwartz, TW | 1 |
| Cullberg, KB; Frimurer, TM; Halkjaer, T; Holst, B; Mokrosinski, J; Schwartz, TW; Underwood, CR | 1 |
7 review(s) available for l 692429 and ibutamoren mesylate
| Article | Year |
|---|---|
Orally active growth hormone secretagogues.
Topics: Animals; Benzazepines; Growth Hormone; Humans; Indoles; Insulin-Like Growth Factor I; Oligopeptides; Spiro Compounds; Structure-Activity Relationship; Tetrazoles | 1998 |
Growth hormone secretagogues as therapeutic agents.
Topics: Adult; Aged; Benzazepines; Child; Growth Disorders; Human Growth Hormone; Humans; Indoles; Male; Obesity; Oligopeptides; Spiro Compounds; Tetrazoles | 1999 |
Growth hormone secretagogues: the clinical future.
Topics: Animals; Benzazepines; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Indoles; Oligopeptides; Spiro Compounds; Tetrazoles | 1999 |
Growth hormone secretagogues: mechanism of action and use in aging.
Topics: Aged; Aging; Animals; Benzazepines; Double-Blind Method; Female; Frail Elderly; Hormone Replacement Therapy; Human Growth Hormone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Indoles; Male; Muscular Atrophy; Oligopeptides; Pituitary Gland, Anterior; Prolactin; Secretory Rate; Somatostatin; Spiro Compounds; Tetrazoles | 1998 |
Growth hormone secretagogue receptor family members and ligands.
Topics: Adenosine; Animals; Benzazepines; Cell Line; Cloning, Molecular; Gene Expression Regulation; Genomic Library; Ghrelin; Growth Hormone-Releasing Hormone; Humans; Indoles; Molecular Structure; Motilin; Oligopeptides; Peptide Hormones; Peptides; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Ghrelin; Sequence Homology, Amino Acid; Spiro Compounds; Tetrazoles; Tissue Extracts | 2001 |
[Ghrelin-related drugs: clinical perspectives].
Topics: Benzazepines; Clinical Trials, Phase I as Topic; Dipeptides; Drug Design; Dwarfism, Pituitary; Ethylamines; Feeding and Eating Disorders; Ghrelin; Growth Hormone; Humans; Ileus; Indoles; Oligopeptides; Peptide Hormones; Sleep Wake Disorders; Spiro Compounds; Stimulation, Chemical; Tetrazoles | 2004 |
Development of growth hormone secretagogues.
Topics: Animals; Base Sequence; Benzazepines; Ghrelin; Hip Fractures; Human Growth Hormone; Humans; Indoles; Molecular Sequence Data; Oligopeptides; Peptide Hormones; Piperidines; Secretory Rate; Spiro Compounds; Tetrazoles | 2005 |
1 trial(s) available for l 692429 and ibutamoren mesylate
| Article | Year |
|---|---|
Growth hormone secretagogues: mechanism of action and use in aging.
Topics: Aged; Aging; Animals; Benzazepines; Double-Blind Method; Female; Frail Elderly; Hormone Replacement Therapy; Human Growth Hormone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Indoles; Male; Muscular Atrophy; Oligopeptides; Pituitary Gland, Anterior; Prolactin; Secretory Rate; Somatostatin; Spiro Compounds; Tetrazoles | 1998 |
4 other study(ies) available for l 692429 and ibutamoren mesylate
| Article | Year |
|---|---|
Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.
Topics: Administration, Oral; Aldosterone; Amino Acid Sequence; Animals; Benzazepines; Cells, Cultured; Dogs; Drug Design; Drug Synergism; Growth Hormone; Indoles; Injections, Intravenous; Luteinizing Hormone; Male; Molecular Sequence Data; Oligopeptides; Pituitary Gland; Prolactin; Rats; Spiro Compounds; Structure-Activity Relationship; Tetrazoles; Thyroxine | 1995 |
Identification of a new G-protein-linked receptor for growth hormone secretagogues.
Topics: Animals; Benzazepines; Binding, Competitive; Growth Hormone; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Indoles; Magnesium; Male; Oligopeptides; Pituitary Gland, Anterior; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Somatotropin; Spiro Compounds; Swine; Tetrazoles | 1996 |
Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling.
Topics: Allosteric Regulation; Amino Acid Sequence; Animals; Arrestin; Benzazepines; Calcium; CREB-Binding Protein; Ghrelin; Humans; Indoles; Inositol Phosphates; Molecular Sequence Data; Molecular Structure; Oligopeptides; Peptide Hormones; Receptors, G-Protein-Coupled; Receptors, Ghrelin; Response Elements; Serum Response Element; Signal Transduction; Spiro Compounds; Tetrazoles; Transcription, Genetic | 2005 |
Overlapping binding site for the endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor.
Topics: Allosteric Regulation; Amino Acid Motifs; Amino Acid Sequence; Amino Acid Substitution; Benzazepines; Binding Sites; Conserved Sequence; Dose-Response Relationship, Drug; Ghrelin; Humans; Hydrophobic and Hydrophilic Interactions; Indoles; Ligands; Models, Molecular; Molecular Sequence Data; Molecular Structure; Oligopeptides; Protein Binding; Protein Structure, Secondary; Receptors, Ghrelin; Spiro Compounds; Structure-Activity Relationship; Tetrazoles | 2009 |